JLHL Q2 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹394 Cr
verified against source
Revenue YoY
11.7%
reported change
EBITDA
₹85.4 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Jupiter Life Line Hospitals reported Q2 FY26 total operating income of 374.4 crores (+11.7% YoY) with EBITDA of 85.4 crores (+9.3% YoY) and PAT of 57.44 crores (+11% YoY). The 54bps EBITDA margin compression to 22.8% was attributed to a one-time 12 crore professional fee provision related to new unbilled revenue accounting policy and Pune hospital seeing lower seasonal infection outbreak versus prior year. H1 performance was stronger at +14.9% revenue growth. The ARPOB improved to 66,100 in H1 (+15% from prior year) driven by case mix optimization and periodic insurance rate revisions. The expansion pipeline remains on track with Diwali hospital expected to commission in Q1 FY27, South Pune construction commenced in Q3 FY26, and Mira on drawing board. Management indicated margins will face dilution as new hospitals ramp up but expects consolidated performance to remain steady. Occupancy at 64.5% on expanded bed base of 150 additional beds vs prior year comparable of 70%.
Colored figures show movement against the previous available record.
Guidance to track
- Doiwali (Thane) hospital is on track to begin operations in Q1 of next financial year (FY27) with recruitment discussions commenced.
- South Pune hospital construction has commenced in Q3 FY26, marking the second greenfield project after Diwali.
- Individual mature hospitals expected to achieve mid-20% EBITDA margins; new hospitals expected to be EBITDA negative in Year 1 and break-even in Year 2 (requiring ~40-45% occupancy).
- Break-even typically occurs at 40-45% occupancy for new hospitals based on company's experience; expansion phases triggered once existing phase reaches 60% occupancy.
Risks flagged
- As Diwali hospital comes up, it will lead to a little dilution in consolidated margins in the first year before stabilizing in subsequent years as it reaches break-even.
- Q2 typically sees occupancy peaks due to infection burden with year-to-year variation of a couple of percentage points; Pune had lower outbreak this year than last year.
- Company has spent ~110 crores on capex in H1 FY26 with 325 crores consolidated debt against liquid investments of ~550 crores; three projects underway may require continued capital deployment.
- Most doctors on minimum guarantee with flexible paid systems; analyst asked about wage inflation policy given expansion mode but management stated no ongoing wage inflation discussions needed as compensation is effort-based.
Key quotes
- We expect that we should broadly be able to complete with our resources and future internal approvals. This debt might kick in if we need or if we get an opportunity to do one more project.
- New hospitals are expected to be EBITDA negative in the first year and break even in the second year. That is our general observation and expectation.
- In early years of a hospital, you generally do more primary and secondary work and less of tertiary work. Because of early years, we should definitely expect a slightly lower ARPOB in Doiwali than we see in matured hospital.
Research modules